A study to determine patient characteristics and assess patient satisfaction with secukinumab treatment of psoriasis based on prior biologic use in real-world settings
Latest Information Update: 17 Jun 2021
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 17 Jun 2021 New trial record
- 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021